MLchartDataset catalogue

Rintatolimod

Term · Oncology and biomedicine · MLC-T-ONC-016550

A synthetic derivative of inosinic acid with antiretroviral and immunomodulatory properties. Atvogen acts through a number of pathways to stimulate intracellular antiviral activity of the immune system: it stimulates interferon production; activates the oligoadenylate synthase-RNase L pathway; stimulates natural killer cell activity; and acts as a non-mitogenic stimulator of the immune system. This agent also inhibits replication of human immunodeficiency virus (HIV) in vitro.

Table 1. Record
IdentifierMLC-T-ONC-016550
FieldOncology and biomedicine
Synonymsatvogen
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016550",
  "term": "Rintatolimod",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic derivative of inosinic acid with antiretroviral and immunomodulatory properties. Atvogen acts through a number of pathways to stimulate intracellular antiviral activity of the immune system: it stimulates interferon production; activates the oligoadenylate synthase-RNase L pathway; stimulates natural killer cell activity; and acts as a non-mitogenic stimulator of the immune system. This agent also inhibits replication of human immunodeficiency virus (HIV) in vitro.",
  "synonyms": [
    "atvogen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/rintatolimod/"
}

Record 14,492 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.